Navigation Links
Enzymatics Reports Latest Growth Figures; Confirms Massachusetts' Emerging Role as Leading Bio-manufacturing Center
Date:6/9/2011

BEVERLY, Mass., June 9, 2011 /PRNewswire/ -- Enzymatics, Inc. announced today that the company, whose revenues have doubled every year since 2007, is forecasting triple the revenue in 2011 over 2010 figures.  It is also expanding its corporate offices and manufacturing facility in Beverly, Massachusetts.  The move is one of several significant milestones for the five year-old, privately held firm that supplies biological reagents as well as bio-processing consulting services to the international scientific and healthcare markets.  It also demonstrates that Massachusetts is no longer just a biotech R&D nursery and is quickly becoming an international center for biotech manufacturing.

Enzymatics' proprietary manufacturing process produces commercial quantities of enzymes measurably superior in purity and consistency to those created in small batches for the research field — but at a much lower cost.  The timing couldn't be better as national and international bioscience and pharmaceutical companies rush to create genomic diagnostics and bio-ceutical drug therapies for mass-market distribution.  Reagents are critical components of these products and in Enzymatics, their manufacturers have found an ideal partner supplier that can scale up to meet large production levels while exceeding purity standards and keeping costs down.  

"Our growth and expansion are a great confirmation that we had the right vision at exactly the right time," states Enzymatics Co-Founder and President Chris Benoit.  "It's been an incredible ride that's about to get even more exciting as we expand our presence in larger, international markets."  The company is currently establishing its first full-service overseas office in Europe. Enzymatics now supports a full time staff of more than 50 and is actively looking to fill an additional 15 positions.  

When asked to share his own perspective on the company's progress, Co-Founder and CEO Stephen Picone replied, "You can sense the future here...We're perfecting new manufacturing technologies built on our core competencies.  And the key collaborations we're setting up will lay the groundwork for the development of novel enzymes.  Both of these initiatives will add a great deal of value to our customer's businesses."

ABOUT ENZYMATICS:  Enzymatics is a leading biotechnology and biosciences manufacturing company that delivers ISO 13485-compliant enzymes of unrivaled purity, consistency, and value to the healthcare and bioscience industries.  For more information, please visit www.enzymatics.com.

Lisa Lazarczyk
781-646-0667 or lisa@lazpr.com


'/>"/>
SOURCE Enzymatics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cantel Medical Reports 18% Increase in Net Income on 24% Increase in Sales
2. Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765
3. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
4. Cyberonics Reports Record Fiscal 2011 Results and Provides Fiscal 2012 Guidance
5. China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results
6. Encision Reports Profitable Fourth Quarter and Fiscal Year 2011 Results
7. Uroplasty Reports Financial Results for the Fiscal Fourth Quarter and Full Year 2011
8. Sinovac Reports Positive Phase I Clinical Trial Results for EV71 Vaccine Candidate Against Hand, Foot & Mouth Disease(HFMD)
9. China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results
10. HealthWarehouse.com Reports 82% Quarter-Over-Quarter Revenue Growth in the First Quarter 2011
11. Omeros Reports Allowance of Additional Patent for Arthroscopic Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... 2016  NxStage Medical, Inc. (Nasdaq: NXTM ... renal care, today announced that Jeffrey H. Burbank ... following schedule of investor conferences. Where applicable, a webcast ... http://ir.nxstage.com/ .   ... NY           Friday, June 10, 2016 1:30 p.m. ET ...
(Date:5/24/2016)... , May 24, 2016  Joe Marziani has joined VMS BioMarketing as senior vice ... officer, today. In his new role, Marziani will lead the company,s business development and ... to improve outcomes. Photo - http://photos.prnewswire.com/prnh/20160523/371089 ... ... ...
(Date:5/24/2016)... KONG , May 24, 2016 ... stent de doble terapia del mundo, introduce catéteres ... arteriovenosa. OrbusNeich, una compañía global especializada ... las vidas, ha expandido su cartera incluyendo productos ... balón JADE™ y Scoreflex™ PTA son los dispositivos ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... ... In Madeira Beach Florida, a small town with 4,300 residents on a ... Madeira Beach United, to oppose two development projects undertaken by their city government that ... rise urban environment. , According to the Tampa Bay Times on May ...
(Date:5/26/2016)... ... May 26, 2016 , ... HealthPostures, ergonomics designer and ... , furniture that may support women during pregnancy. Potential benefits of using the Stance ... rest and comfort and healthier levels of sitting and standing. , Need for the ...
(Date:5/25/2016)... ... May 25, 2016 , ... ... Association/American Stroke Association's Get With The Guidelines®-Stroke Gold Plus Achievement Award with ... second for Memorial Healthcare System, recognizes its commitment to emergency stroke care ...
(Date:5/25/2016)... ... May 25, 2016 , ... Serenity Recovery, a ... video highlighting one of the many supplemental program options offered at their rehabilitation ... 5 th Degree Black Belt in the Shorin-ryu style of Karate that originated ...
(Date:5/25/2016)... ... May 25, 2016 , ... ... Program (KOHP), a $500,000 two-year pilot initiative to improve oral health-related awareness, education, ... professional development for health care providers and promote best practices in 10 New ...
Breaking Medicine News(10 mins):